Paradigm Biocapital Advisors LP
Known title: 10% OwnerCIK: 0001855655
Paradigm Biocapital Advisors LP's purchase track record
Paradigm Biocapital Advisors LP has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/6/2023 | OLMA | $1.16M | +22.1% | +18.8% | +17.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OLMA | ▼ Sell | Open Market | 1,870,499 | $27.9M | 8/1/2024 | View on chart |
| OLMA | ▼ Sell | Open Market | 529,501 | $7.9M | 8/1/2024 | View on chart |
| OLMA | ▲ Buy | Open Market | 100,000 | $1.2M | 12/6/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
OLMA Joins 12 Healthcare Stocks Moving in Pre-Market
OLMA was among 12 healthcare stocks that moved in Wednesday's pre‑market session, signaling early interest from traders. The move comes while the stock sits near its 52‑week low and a low RSI of 19.1, suggesting it may be oversold. This early activity could reflect new market sentiment or a reaction to broader healthcare sector dynamics.
OLMA Joins 12 Healthcare Stocks Moving in Pre-Market. OLMA was among 12 healthcare stocks that moved in Wednesday's pre‑market session, signaling early interest from traders. The move comes while the stock sits near its 52‑week low and a low RSI of 19.1, suggesting it may be oversold. This early activity could reflect new market sentiment or a reaction to broader healthcare sector dynamics.